Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition
Abstract Major progress has been made clinically in inhibiting the programmed death receptor 1 (PD-1)/PD-L1 interaction to enhance T cell-mediated immune function, yet the effectiveness of anti-PD-L1/PD-1 agents in enhancing natural killer (NK) cell’s function remains largely unknown. Susceptibiliti...
Guardado en:
Autores principales: | Li Yang, MingJing Shen, Li Jun Xu, Xiaodong Yang, Ying Tsai, Peter C. Keng, Yuhchyau Chen, Soo Ok Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c269617aaab84a4390a2877858fd746b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum]
por: Hu H, et al.
Publicado: (2021) -
Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer
por: Adrián Sánchez-Fdez, et al.
Publicado: (2021) -
Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells
por: Charlène Niogret, et al.
Publicado: (2019) -
Involvement of the MEK-ERK/p38-CREB/c-fos signaling pathway in Kir channel inhibition-induced rat retinal Müller cell gliosis
por: Feng Gao, et al.
Publicado: (2017) -
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
por: Yu Hui Kang, et al.
Publicado: (2019)